2023
SAT-283 Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma
Cadamuro M, Sarcognato S, Camerotto R, Girardi N, Lasagni A, Zanus G, Cillo U, Gringeri E, Morana G, Strazzabosco M, Campello E, Simioni P, Guido M, Fabris L. SAT-283 Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma. Journal Of Hepatology 2023, 78: s564-s565. DOI: 10.1016/s0168-8278(23)01358-2.Peer-Reviewed Original Research
2012
Development of the bile ducts: Essentials for the clinical hepatologist
Strazzabosco M, Fabris L. Development of the bile ducts: Essentials for the clinical hepatologist. Journal Of Hepatology 2012, 56: 1159-1170. PMID: 22245898, PMCID: PMC3328609, DOI: 10.1016/j.jhep.2011.09.022.Peer-Reviewed Original ResearchConceptsLiver diseaseBile ductBiliary structuresFibropolycystic liver diseaseExtrahepatic biliary treeBiliary developmentLiver repair mechanismsHepatocellular damageBiliary treeDuctular reactionLiver repairReparative responseAlagille syndromePathogenic aspectsClinical hepatologistsCholangiopathyGrowth factorParacrine signalsEmbryonic lifeDiseaseDuctRepair mechanismsHepatologistsSyndromeTranscription factors
1987
Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration
Iemmolo R, Lirussi F, Oselladore D, Rossoni R, Muraca M, Orlando R, Nassuato G, Strazzabosco M, Okolicsányi L. Biliary Lipid Composition after Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of Short-Term Ursodeoxycholic Acid Administration. 1987, 125-131. DOI: 10.1007/978-3-642-72631-6_17.ChaptersSphincter of OddiEndoscopic sphincterotomyUrsodeoxycholic acid administrationBiliary lipid compositionTreatment of choicePostcholecystectomy patientsPostcholecystectomy syndromeAcid administrationMotor dysfunctionMajor causeSphincterotomyPatientsLipid compositionOddiStenosisSphincterDysfunctionSyndromeAdministration
1985
Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.
Okolicsanyi L, Venuti M, Strazzabosco M, Biral A, Orlando R, Iemmolo R, Nassuato G, Muraca M, Padrini G, Miglioli P. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses. International Journal Of Clinical Pharmacology And Therapeutics 1985, 23: 434-8. PMID: 4044077.Peer-Reviewed Original Research